HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension

Autor: Deborah Molehin, Bum-Yong Kang, Justin M. Smith, Sonia C. Flores, Laurence Huang, Roy L. Sutliff, Cari F. Kessing, Kevin Pruitt, Edgar G. Martinez, Edu B Suárez-Martínez, Bryan McNair, Kaiser M. Bijli, Sushma K. Cribbs, Laura Pumarejo-Gomez, Priscilla Y. Hsue, Brandy E. Wade, Sharilyn Almodovar, David M. Guidot, Kristi M. Porter, William R. Tyor, Ethan A. Salazar, Robert Alexis Lopez-Astacio, Jaritza Perez Hernandez
Jazyk: angličtina
Rok vydání: 2020
Předmět:
0301 basic medicine
Male
viruses
lcsh:Medicine
HIV Infections
Pathogenesis
030204 cardiovascular system & hematology
HIV Envelope Protein gp120
CXCR4
Transgenic
Cohort Studies
Chemokine receptor
0302 clinical medicine
Receptors
2.1 Biological and endogenous factors
lcsh:Science
Lung
Cells
Cultured

Inbred F344
Leukotriene
Pulmonary Arterial Hypertension
Cultured
Multidisciplinary
medicine.diagnostic_test
biology
Molecular medicine
virus diseases
Middle Aged
Infectious Diseases
medicine.anatomical_structure
Phenotype
Arachidonate 5-lipoxygenase
HIV/AIDS
Female
Rats
Transgenic

Infection
Biotechnology
Adult
Receptors
CXCR4

Genotype
Anti-HIV Agents
Cells
Pulmonary Artery
Article
03 medical and health sciences
Genetics
medicine
Animals
Humans
Tropism
Arachidonate 5-Lipoxygenase
Animal
business.industry
lcsh:R
Endothelial Cells
Rats
Inbred F344

Rats
Disease Models
Animal

Viral Tropism
030104 developmental biology
Bronchoalveolar lavage
Disease Models
Immunology
biology.protein
HIV-1
lcsh:Q
business
Zdroj: Scientific Reports
Scientific reports, vol 10, iss 1
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
ISSN: 2045-2322
Popis: Pulmonary Arterial Hypertension (PAH) is overrepresented in People Living with Human Immunodeficiency Virus (PLWH). HIV protein gp120 plays a key role in the pathogenesis of HIV-PAH. Genetic changes in HIV gp120 determine viral interactions with chemokine receptors; specifically, HIV-X4 viruses interact with CXCR4 while HIV-R5 interact with CCR5 co-receptors. Herein, we leveraged banked samples from patients enrolled in the NIH Lung HIV studies and used bioinformatic analyses to investigate whether signature sequences in HIV-gp120 that predict tropism also predict PAH. Further biological assays were conducted in pulmonary endothelial cells in vitro and in HIV-transgenic rats. We found that significantly more persons living with HIV-PAH harbor HIV-X4 variants. Multiple HIV models showed that recombinant gp120-X4 as well as infectious HIV-X4 remarkably increase arachidonate 5-lipoxygenase (ALOX5) expression. ALOX5 is essential for the production of leukotrienes; we confirmed that leukotriene levels are increased in bronchoalveolar lavage fluid of HIV-infected patients. This is the first report associating HIV-gp120 genotype to a pulmonary disease phenotype, as we uncovered X4 viruses as potential agents in the pathophysiology of HIV-PAH. Altogether, our results allude to the supplementation of antiretroviral therapy with ALOX5 antagonists to rescue patients with HIV-X4 variants from fatal PAH.
Databáze: OpenAIRE